Even after the coronavirus is tamed, changes being made now to clinical trial design and execution could benefit the clinical research industry moving forward
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.